About Quincy Bioscience
Quincy Bioscience is a Healthcare company based in Madison (United States) founded in 2004. Novel technologies for cognitive support in aging are developed. Quincy Bioscience has raised $5.18 million across 2 funding rounds from investors including Capitala Group. The company has 78 employees. Quincy Bioscience offers products and services including Prevagen. Its focus areas include Life Sciences, Nutraceuticals Tech, Dietary Supplements and Disease Specific. Its competitors include First Person Group, BrainGear and Sevo Nutraceuticals; 3 of its 3 listed competitors have raised funding.
Company details
Quincy Bioscience was founded in 2004 in Madison, United States, as a biotechnology firm. Novel technologies are discovered, developed, and commercialized to address cognitive issues, including mild memory loss associated with aging. Operations center on impaired calcium homeostasis, with products utilizing the patented protein Apoaequorin, a calcium-binding protein sourced from jellyfish. Focus remains on supporting cognitive function through these innovations.
- Headquarters Madison, United States
- Employees 78
- SectorsHealthcare
- Website quincybioscience.com
- Social LinkedIn X
- Total Equity Funding$5.18M (USD)
in 2 rounds
- Investors
- Employee Count78
Products & Services of Quincy Bioscience
Quincy Bioscience offers a comprehensive portfolio of products and services, including Prevagen.
Over-the-counter product for supporting memory and brain health.
Funding Insights of Quincy Bioscience
Quincy Bioscience has successfully raised a total of $5.18M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.18M
- Total Rounds 2
- First Round $5.18M
(May 2009)
- Investors Count 1
All 2 funding rounds of Quincy Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2014 | Debt – Conventional | – | – | ||
| May 2009 | $5.18M | Series B | – | – | – |
1 investors in total: 1 institutional.
Investors in Quincy Bioscience
Quincy Bioscience has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Capitala Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Global multi-sector investments are managed by the private equity firm. | capitalagroup.com | Charlotte, United States |
Investor details for Quincy Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Quincy Bioscience
3 dated milestones of Quincy Bioscience across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Quincy Bioscience is founded.
- Funding First funding round of $5.2M.
- Funding Latest funding round, Debt – Conventional,.
Competitors of Quincy Bioscience
Quincy Bioscience has 3 listed competitors in our database, 3 of them funded. They include First Person Group, BrainGear and Sevo Nutraceuticals.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| firstpersongroup.com | 2016 | Los Angeles, United States | $1.27M | Functional mushroom ingredients for mental health are supplied. | ||
| braingear.me | 2013 | San Francisco, United States | $2.25M | Nutrient supplements for brain health are developed. | ||
| sevonutraceuticals.com | 2012 | Boston, United States | $475,000 | Science-based cognitive health nutraceuticals are licensed and commercialized. |
Detailed competitors of Quincy Bioscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Quincy Bioscience
The website of Quincy Bioscience (quincybioscience.com) receives about 2.7K visits a month.
- Monthly visits2.7K
▲ 48.4% vs previous month
Websites whose visitors overlap most with Quincy Bioscience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
prevagen.com | prevagen.com | 100% | #582,566 | – | |
longevity.about.com | longevity.about.com | 87% | – | ||
| patientslikeme.com | 87% | 123K | #323,351 | View details | |
townsendletter.com | townsendletter.com | 53% | #1,427,911 | – | |
holisticprimarycare.net | holisticprimarycare.net | 36% | #3,671,317 | – |
Top companies in Nutraceutical & Food-as-Medicine Platforms
3 companies that operate in the same segment as Quincy Bioscience (Nutraceutical & Food-as-Medicine Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapies for metabolic health in chronic disease patients are provided. | 2014 | San Francisco, California, United States | USD 401.78 M | 910 | ||
Personalized gut health solutions are provided by ZOE. | 2017 | New Castle, Pennsylvania, United States | USD 15 M | |||
Machine learning-based bioinformatics solutions for health insights are provided. | 2016 | Los Alamos, New Mexico, United States | USD 301.57 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Quincy Bioscience
Complete news archive for Quincy Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Quincy Bioscience
Quincy Bioscience was founded in 2004 and raised its 1st funding round 5 years after it was founded.
Quincy Bioscience is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
Quincy Bioscience is a funded company, having raised a total of $5.18M across 2 funding rounds to date. The company's 1st funding round was a Series B of $5.18M, raised on May 2009.
Quincy Bioscience has 78 employees.
Quincy Bioscience was founded in 2004 in Madison, United States, as a biotechnology firm. Novel technologies are discovered, developed, and commercialized to address cognitive issues, including mild memory loss associated with aging. Operations center on impaired calcium homeostasis, with products utilizing the patented protein Apoaequorin, a calcium-binding protein sourced from jellyfish. Focus remains on supporting cognitive function through these innovations.
Quincy Bioscience's top competitors include First Person Group, BrainGear and Sevo Nutraceuticals.
Quincy Bioscience offers Prevagen.
Quincy Bioscience has 1 investor. Key investors include Capitala Group.